Skip to main navigation Skip to search Skip to main content

Procalcitonin as an early marker of infection in neonates and children

  • A. M.C.Van Rossum
  • , R. W. Wulkan
  • , A. M. Oudesluys-Murphy*
  • *Corresponding author for this work
  • Medical Centre Rijnmond-Zuid

Research output: Contribution to journal › Review article › Academic › peer-review

285 Citations (Scopus)

Abstract

A child or neonate presenting with fever is a common medical problem. To differentiate between those with a severe bacterial infection and those with a localised bacterial or a viral infection can be a challenge. This review provides an overview of neonatal and paediatric studies that assess the use of procalcitonin as an early marker of bacterial infection. Procalcitonin is an excellent marker for severe, invasive bacterial infection in children. However, the use of procalcitonin in the diagnosis of neonatal bacterial infection is complicated, but if correctly used procalcitonin results in a higher specificity than C-reactive protein. In addition, procalcitonin has been shown to correlate with severity of disease (urinary tract infections and sepsis), and can therefore be used as a prognostic marker. Procalcitonin is therefore a useful additional tool for the diagnosis of bacterial disease in neonates and children.

Original languageEnglish
Pages (from-to)620-630
Number of pages11
JournalLancet Infectious Diseases
Volume4
Issue number10
DOIs
Publication statusPublished - 1 Oct 2004
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Procalcitonin as an early marker of infection in neonates and children'. Together they form a unique fingerprint.

Cite this